OPPM
Opus Point Partners Management Portfolio holdings
AUM
$46.9M
1-Year Return
4.17%
This Quarter Return
+18.25%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
–
AUM
$150M
AUM Growth
+$24.2M
(+19%)
Cap. Flow
+$10.3M
Cap. Flow
% of AUM
6.88%
Top 10 Holdings %
Top 10 Hldgs %
43.11%
Holding
70
New
14
Increased
21
Reduced
14
Closed
12
Top Buys
| 1 |
Amgen
AMGN
|
$4.89M |
| 2 |
iShares Biotechnology ETF
IBB
|
$3.92M |
| 3 |
Gilead Sciences
GILD
|
$2.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
$2.83M |
| 5 |
Merck
MRK
|
$2.59M |
Top Sells
| 1 |
Bio-Techne
TECH
|
$4.35M |
| 2 |
CPHD
Cepheid Inc
CPHD
|
$4.07M |
| 3 |
AstraZeneca
AZN
|
$2.95M |
| 4 |
Biogen
BIIB
|
$2.14M |
| 5 |
Mettler-Toledo International
MTD
|
$1.87M |
Sector Composition
| 1 | Healthcare | 83.31% |
| 2 | Financials | 0% |
